158 related articles for article (PubMed ID: 37380453)
1. A Pancreatic Collision Tumor Comprising Mantle Cell Lymphoma and Adenocarcinoma: A Case Report and Literature Review.
Sugaya R; Taniguchi A; Abe M; Ozawa I; Kirito K; Hatakeyama S
Intern Med; 2024 Feb; 63(4):553-558. PubMed ID: 37380453
[TBL] [Abstract][Full Text] [Related]
2. Collision tumors: pancreatic adenocarcinoma and mantle cell lymphoma.
Dasanu CA; Shimanovsky A; Rotundo EK; Posteraro AF; Cooper DL; Atienza JA
JOP; 2013 Jul; 14(4):458-62. PubMed ID: 23846948
[TBL] [Abstract][Full Text] [Related]
3. Morphological spectrum of cyclin D1-positive mantle cell lymphoma: study of 168 cases.
Yatabe Y; Suzuki R; Matsuno Y; Tobinai K; Ichinohazama R; Tamaru J; Mizoguchi Y; Hashimoto Y; Yamaguchi M; Kojima M; Uike N; Okamoto M; Isoda K; Ichimura K; Morishima Y; Seto M; Suchi T; Nakamura S
Pathol Int; 2001 Oct; 51(10):747-61. PubMed ID: 11881727
[TBL] [Abstract][Full Text] [Related]
4. [Detection of cyclin D1 mRNA by reverse transcription-polymerase chain reaction in paraffin-embedded tissues and its diagnostic significance for mantle cell lymphoma].
Shui RH; Wei YK; Sun MH; Wang J; Shi DR; Zhang TM; Jin AP; Zhu XZ
Zhonghua Bing Li Xue Za Zhi; 2005 Aug; 34(8):514-8. PubMed ID: 16383299
[TBL] [Abstract][Full Text] [Related]
5. Mantle cell lymphoma in the ocular adnexal region.
Looi A; Gascoyne RD; Chhanabhai M; Connors JM; Rootman J; White VA
Ophthalmology; 2005 Jan; 112(1):114-9. PubMed ID: 15629830
[TBL] [Abstract][Full Text] [Related]
6. Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma.
Yatabe Y; Suzuki R; Tobinai K; Matsuno Y; Ichinohasama R; Okamoto M; Yamaguchi M; Tamaru J; Uike N; Hashimoto Y; Morishima Y; Suchi T; Seto M; Nakamura S
Blood; 2000 Apr; 95(7):2253-61. PubMed ID: 10733493
[TBL] [Abstract][Full Text] [Related]
7. A cyclin D1-negative mantle cell lymphoma with an IGL-CCND2 translocation that relapsed with blastoid morphology and aggressive clinical behavior.
Kurita D; Takeuchi K; Kobayashi S; Hojo A; Uchino Y; Sakagami M; Ohtake S; Takahashi H; Miura K; Iriyama N; Sugitani M; Miyoshi H; Hatta Y; Ohshima K; Takei M
Virchows Arch; 2016 Oct; 469(4):471-6. PubMed ID: 27457074
[TBL] [Abstract][Full Text] [Related]
8. Mantle Cell Lymphoma With MYC Rearrangement: A Report of 17 Patients.
Hu Z; Medeiros LJ; Chen Z; Chen W; Li S; Konoplev SN; Lu X; Pham LV; Young KH; Wang W; Hu S
Am J Surg Pathol; 2017 Feb; 41(2):216-224. PubMed ID: 27776009
[TBL] [Abstract][Full Text] [Related]
9. Proapoptotic protein BIM as a novel prognostic marker in mantle cell lymphoma.
Wang JD; Katz SG; Morgan EA; Yang DT; Pan X; Xu ML
Hum Pathol; 2019 Nov; 93():54-64. PubMed ID: 31425695
[TBL] [Abstract][Full Text] [Related]
10. Detection of cyclin D1 overexpression by real-time reverse-transcriptase-mediated quantitative polymerase chain reaction for the diagnosis of mantle cell lymphoma.
Suzuki R; Takemura K; Tsutsumi M; Nakamura S; Hamajima N; Seto M
Am J Pathol; 2001 Aug; 159(2):425-9. PubMed ID: 11485900
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling.
Fu K; Weisenburger DD; Greiner TC; Dave S; Wright G; Rosenwald A; Chiorazzi M; Iqbal J; Gesk S; Siebert R; De Jong D; Jaffe ES; Wilson WH; Delabie J; Ott G; Dave BJ; Sanger WG; Smith LM; Rimsza L; Braziel RM; Müller-Hermelink HK; Campo E; Gascoyne RD; Staudt LM; Chan WC;
Blood; 2005 Dec; 106(13):4315-21. PubMed ID: 16123218
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathologic features and prognosis of gastrointestinal mantle cell lymphoma].
Hou WH; Wei P; Xie JL; Zheng YY; Zhang YL; Zhou XG
Zhonghua Bing Li Xue Za Zhi; 2018 Oct; 47(10):763-768. PubMed ID: 30317731
[No Abstract] [Full Text] [Related]
13. Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression.
Zeng W; Fu K; Quintanilla-Fend L; Lim M; Ondrejka S; Hsi ED
Am J Surg Pathol; 2012 Feb; 36(2):214-9. PubMed ID: 22251940
[TBL] [Abstract][Full Text] [Related]
14. From the archives of MD Anderson Cancer Center: Untreated leukemic non-nodal mantle cell lymphoma with relapse as pleomorphic variant mantle cell lymphoma 21 years later.
Fang H; Medeiros LJ; Tang Z; Wang W; Ok CY; Patel KP; Khoury JD; Thakral B
Ann Diagn Pathol; 2021 Feb; 50():151649. PubMed ID: 33189964
[TBL] [Abstract][Full Text] [Related]
15. SOX11 is useful in differentiating cyclin D1-positive diffuse large B-cell lymphoma from mantle cell lymphoma.
Hsiao SC; Cortada IR; Colomo L; Ye H; Liu H; Kuo SY; Lin SH; Chang ST; Kuo TU; Campo E; Chuang SS
Histopathology; 2012 Oct; 61(4):685-93. PubMed ID: 22642745
[TBL] [Abstract][Full Text] [Related]
16. A collision tumor of nasopharyngeal carcinoma and primary mantle cell lymphoma in the nasopharynx: a case report and review of the literature.
Jiang M; Yuan XP; Zhang H; Li CQ; Mao YL; Chen WL
BMC Oral Health; 2023 Sep; 23(1):672. PubMed ID: 37718438
[TBL] [Abstract][Full Text] [Related]
17. SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype.
Mozos A; Royo C; Hartmann E; De Jong D; Baró C; Valera A; Fu K; Weisenburger DD; Delabie J; Chuang SS; Jaffe ES; Ruiz-Marcellan C; Dave S; Rimsza L; Braziel R; Gascoyne RD; Solé F; López-Guillermo A; Colomer D; Staudt LM; Rosenwald A; Ott G; Jares P; Campo E
Haematologica; 2009 Nov; 94(11):1555-62. PubMed ID: 19880778
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D1-CDK4 activity drives sensitivity to bortezomib in mantle cell lymphoma by blocking autophagy-mediated proteolysis of NOXA.
Heine S; Kleih M; Giménez N; Böpple K; Ott G; Colomer D; Aulitzky WE; van der Kuip H; Silkenstedt E
J Hematol Oncol; 2018 Sep; 11(1):112. PubMed ID: 30180865
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathologic features of mantle cell lymphoma and the significance of cyclin D1 in diagnosis].
He X; Li G; Liu W; Lin Y; Li F; Liao D
Zhonghua Bing Li Xue Za Zhi; 2002 Aug; 31(4):300-4. PubMed ID: 12417084
[TBL] [Abstract][Full Text] [Related]
20. A cyclin-D1 interaction with BAX underlies its oncogenic role and potential as a therapeutic target in mantle cell lymphoma.
Beltran E; Fresquet V; Martinez-Useros J; Richter-Larrea JA; Sagardoy A; Sesma I; Almada LL; Montes-Moreno S; Siebert R; Gesk S; Calasanz MJ; Malumbres R; Rieger M; Prosper F; Lossos IS; Piris MA; Fernandez-Zapico ME; Martinez-Climent JA
Proc Natl Acad Sci U S A; 2011 Jul; 108(30):12461-6. PubMed ID: 21746927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]